ATS 2018 International Conference - Mobile

Effect of Twice-Daily Aclidinium/Formoterol versus Monotherapy or Tiotropium on 24-Hour Bronchodilation and Symptom Control in Patients with COPD: Results from AMPLIFY [Board No. 609]

Location: Board no. 609

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Monday

May

21

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Rosa Segarra

phd
AstraZeneca

Henrik Watz

MD
Pulmonary Research Inst;Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Cen;Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research

Edward M. Kerwin

phd
Clinical Research Institute;Clinical Research Institute of Southern Oregon, PC;Crisor, LLC c/o Clinical Research Institute of Southern Oregon, Inc.

Diana Jarreta

BSc
AstraZeneca

Sanjay Sethi

md
Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo;State University of New York at Buffalo;University at Buffalo;University at Buffalo, State University of New

Esther Garcia Gil

phd
AstraZeneca;AstraZeneca R&D Centre

Eduard Molins

phd
AstraZeneca

Robert Mroz

MD
Centrum Medycyny Oddechowej and Medical University of Białystok

Gary T. Ferguson

MD
Pulmonary Research Institute of Southeast Michigan

View Abstract

Effect of Twice-Daily Aclidinium/Formoterol versus Monotherapy or Tiotropium on 24-Hour Bronchodilation and Symptom Control in Patients with COPD: Results from AMPLIFY

Parent Sessions

B102 - CLINICAL TRIALS AND STUDIES IN COPD...
05-21-2018 2:15 PM - 4:15 PM